BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33341213)

  • 1. A case for palliative dermatology: COVID-19-related dermatoses.
    Ho B; Ray A
    Clin Dermatol; 2020; 38(6):768-769. PubMed ID: 33341213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater inhibition of dermographia with a combination of H1 and H2 antagonists.
    Mansfield LE; Smith JA; Nelson HS
    Ann Allergy; 1983 Apr; 50(4):264-5. PubMed ID: 6132569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 pandemic and the skin: what should dermatologists know?
    Darlenski R; Tsankov N
    Clin Dermatol; 2020; 38(6):785-787. PubMed ID: 33341217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Corticosteroids and antihistaminics combined in the treatment of dermatoses].
    Peirone F
    Minerva Med; 1967 Jan; 58(9):285-8. PubMed ID: 4381515
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing the treatment of solar urticaria. The dose-response as a quantifying approach.
    Michell P; Hawk JL; Shafrir A; Corbett MF; Magnus IA
    Dermatologica; 1980; 160(3):198-207. PubMed ID: 6104610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe urticarial rash as the initial symptom of COVID-19 infection.
    Pagali S; Parikh RS
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33766974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of acrivastine versus chlorpheniramine in the treatment of chronic idiopathic urticaria.
    Gale AE; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():25B-27B. PubMed ID: 2569998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urticaria as a first clinical manifestation of COVID-19.
    Veraldi S; Romagnuolo M; Benzecry V
    Eur J Dermatol; 2020 Dec; 30(6):737-738. PubMed ID: 33459263
    [No Abstract]   [Full Text] [Related]  

  • 9. Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19) infection.
    Hassan K
    BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32641443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of four antihistamines in chronic urticaria.
    Youngchaiyud U
    J Med Assoc Thai; 1988 Oct; 71(10):548-52. PubMed ID: 2907911
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19: An overview for dermatologists.
    Sanghvi AR
    Int J Dermatol; 2020 Dec; 59(12):1437-1449. PubMed ID: 33107038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-Coronavirus-2 and acute urticaria.
    Falkenhain-López D; Sánchez-Velázquez A; López-Valle A; Ortiz-Frutos FJ
    Int J Dermatol; 2020 Jul; 59(7):867-868. PubMed ID: 32441802
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous manifestations in an Italian military COVID hub.
    Di Nunno D; Laghi A; Troiani G; Marseglia B; Anelli L; Farina E; Tarricone F; Mammana G; Catalano C; Bonito A; De Capua A; Caramanico G; Blasioli S; Astorino S
    G Ital Dermatol Venereol; 2020 Oct; 155(5):632-635. PubMed ID: 33295741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact and Consequences of SARS-CoV-2 Pandemic on a Single University Dermatology Outpatient Clinic in Germany.
    Wang R; Helf C; Tizek L; Neuhauser R; Eyerich K; Zink A; Eberlein B; Biedermann T; Brockow K; Boehner A
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32858870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of therapy in chronic urticaria.
    Harvey RP; Wegs J; Schocket AL
    J Allergy Clin Immunol; 1981 Oct; 68(4):262-6. PubMed ID: 6116728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous manifestation during COVID-19 pandemic.
    Galli E; Cipriani F; Ricci G; Maiello N
    Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26(Suppl 26):89-91. PubMed ID: 33236439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorpheniramine, an Old Drug with New Potential Clinical Applications: A Comprehensive Review of the Literature.
    Rizvi SAA; Ferrer G; Khawaja UA; Sanchez-Gonzalez MA
    Curr Rev Clin Exp Pharmacol; 2024; 19(2):137-145. PubMed ID: 35652393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of urticaria. An evidence-based evaluation of antihistamines.
    Lee EE; Maibach HI
    Am J Clin Dermatol; 2001; 2(1):27-32. PubMed ID: 11702618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yellow urticaria associated with hepatitis type-C liver cirrhosis.
    Imanishi H; Tsuruta D; Kobayashi H; Ishii M
    J Dermatol; 2006 Nov; 33(11):823-4. PubMed ID: 17074004
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute urticaria preceding other COVID-19-associated manifestations-A case report.
    Chen V; Escandon Brehm J; Bellodi Schmidt F
    Pediatr Dermatol; 2021 Mar; 38(2):455-457. PubMed ID: 33410205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.